Free Trial

DXC Technology (DXC) Competitors

DXC Technology logo
$20.50 -0.13 (-0.61%)
As of 01/17/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DXC vs. RTO, CART, ALLE, MEDP, ULS, WPP, GLOB, HQY, STN, and BILI

Should you be buying DXC Technology stock or one of its competitors? The main competitors of DXC Technology include Rentokil Initial (RTO), Maplebear (CART), Allegion (ALLE), Medpace (MEDP), UL Solutions (ULS), WPP (WPP), Globant (GLOB), HealthEquity (HQY), Stantec (STN), and Bilibili (BILI). These companies are all part of the "business services" industry.

DXC Technology vs.

DXC Technology (NYSE:DXC) and Rentokil Initial (NYSE:RTO) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership.

DXC Technology has a beta of 1.66, indicating that its share price is 66% more volatile than the S&P 500. Comparatively, Rentokil Initial has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.

DXC Technology has a net margin of 0.18% compared to Rentokil Initial's net margin of 0.00%. DXC Technology's return on equity of 20.42% beat Rentokil Initial's return on equity.

Company Net Margins Return on Equity Return on Assets
DXC Technology0.18% 20.42% 4.69%
Rentokil Initial N/A N/A N/A

In the previous week, Rentokil Initial had 23 more articles in the media than DXC Technology. MarketBeat recorded 27 mentions for Rentokil Initial and 4 mentions for DXC Technology. DXC Technology's average media sentiment score of 0.87 beat Rentokil Initial's score of 0.07 indicating that DXC Technology is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DXC Technology
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Rentokil Initial
3 Very Positive mention(s)
0 Positive mention(s)
21 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

96.2% of DXC Technology shares are owned by institutional investors. Comparatively, 9.9% of Rentokil Initial shares are owned by institutional investors. 0.5% of DXC Technology shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

DXC Technology received 407 more outperform votes than Rentokil Initial when rated by MarketBeat users. Likewise, 61.25% of users gave DXC Technology an outperform vote while only 30.77% of users gave Rentokil Initial an outperform vote.

CompanyUnderperformOutperform
DXC TechnologyOutperform Votes
411
61.25%
Underperform Votes
260
38.75%
Rentokil InitialOutperform Votes
4
30.77%
Underperform Votes
9
69.23%

Rentokil Initial has lower revenue, but higher earnings than DXC Technology. Rentokil Initial is trading at a lower price-to-earnings ratio than DXC Technology, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DXC Technology$13.67B0.27$91M$0.08256.34
Rentokil Initial$6.68B1.80$473.93M$1.5415.46

DXC Technology currently has a consensus price target of $20.88, suggesting a potential upside of 1.80%. Rentokil Initial has a consensus price target of $29.00, suggesting a potential upside of 21.77%. Given Rentokil Initial's stronger consensus rating and higher probable upside, analysts clearly believe Rentokil Initial is more favorable than DXC Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DXC Technology
1 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.88
Rentokil Initial
0 Sell rating(s)
5 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.63

Summary

DXC Technology beats Rentokil Initial on 11 of the 19 factors compared between the two stocks.

Get DXC Technology News Delivered to You Automatically

Sign up to receive the latest news and ratings for DXC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DXC vs. The Competition

MetricDXC TechnologyData processing & preparation IndustryComputer SectorNYSE Exchange
Market Cap$3.71B$4.38B$27.12B$19.94B
Dividend YieldN/A3.00%2.78%3.71%
P/E Ratio256.3433.94236.9041.41
Price / Sales0.277.243,720.9916.25
Price / Cash1.7330.5534.3219.84
Price / Book1.226.128.395.76
Net Income$91M$44.77M$669.90M$993.25M
7 Day Performance3.93%3.97%3.66%3.12%
1 Month Performance-0.46%3.11%4.89%4.75%
1 Year Performance-10.85%19.24%24.37%18.83%

DXC Technology Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DXC
DXC Technology
2.3929 of 5 stars
$20.51
-0.6%
$20.88
+1.8%
-10.8%$3.71B$13.67B256.34130,000
RTO
Rentokil Initial
3.1414 of 5 stars
$23.87
+1.9%
$29.00
+21.5%
-8.8%$12.05B$5.41B16.9362,900
CART
Maplebear
4.1399 of 5 stars
$44.29
+0.1%
$47.63
+7.5%
+78.1%$11.38B$3.30B29.723,380Short Interest ↓
ALLE
Allegion
4.0193 of 5 stars
$127.87
+1.3%
$140.83
+10.1%
+9.4%$11.12B$3.72B19.6411,000Short Interest ↑
MEDP
Medpace
4.5467 of 5 stars
$350.51
-0.1%
$380.56
+8.6%
+14.1%$10.89B$2.07B30.695,900
ULS
UL Solutions
1.6041 of 5 stars
$50.04
+1.5%
$49.00
-2.1%
N/A$10.01B$2.82B0.0015,233
WPP
WPP
1.3241 of 5 stars
$43.87
-0.2%
N/A-2.0%$9.47B$14.85B7.46114,732
GLOB
Globant
3.9287 of 5 stars
$205.50
-1.0%
$230.44
+12.1%
-7.7%$8.85B$2.35B53.6629,150Short Interest ↑
HQY
HealthEquity
2.9015 of 5 stars
$101.21
+0.9%
$110.71
+9.4%
+40.0%$8.77B$1.15B92.853,150
STN
Stantec
3.7424 of 5 stars
$76.35
+0.3%
N/A-3.5%$8.71B$7.15B34.7028,000Positive News
BILI
Bilibili
2.7103 of 5 stars
$16.09
+0.8%
$19.69
+22.4%
+85.7%$6.67B$25.45B-17.498,801

Related Companies and Tools


This page (NYSE:DXC) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners